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The matrix of the constructs had resultant matrix of type II collagen
and proteogrycan which conﬁrmed histochemically. The constructs
formed via cell condensation at 107cells/cm2 grew in thickness
until the day 14 of P1 culture. They grew in size until the day 28 of
P1 culture.
The tissues were stained strongly with safraninO, and there were
partially columnar pattern. Immunohistochemical analysis revealed
that typeIIcollagen was abundantly deposited in the tissue. More-
over with toluidine blue staining, there was a metachromatic matrix.
Interestingly, LIPUS group was also more strongly stained than
sham group by histology.
In vivo study, histology of repair tissue with the chondrocyte plate
in 2wks was not signiﬁcant different about LIPUS group and non-
treated LIPUS (sham) group. But the treated by the plate group,
LIPUS and sham group, were repaired better than control group
by histology.
Conclusions: The chondrocytes of P1 cells prepared at
107cells/cm2 developed into the scaffold-free chondrocyte plate
which was similar to native cartilage under existing cell-cell inter-
actions.
As a result for application of LIPUS, we could stimulate the matrix
synthesis of the scaffold-free chondrocytes plate in vitro study.
In vivo study, we didn’t show the effect of LIPUS to stimulate the
matrix synthesis of the plate.
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Purpose: Chondrocyte hypertrophic differentiation is an essential
process during endochondral bone formation, however it hampers
the application of many cartilage regenerative techniques and may
play a role at the onset of osteoarthritis. Clinically, heterotopic bone
formation after orthopaedic surgery is suppressed by non-steroidal
anti-inﬂammatory drugs (NSAIDs) and recent studies point to an
essential role of Cyclooxygenase-2 (COX-2) in osteocytes during
endochondral ossiﬁcation. COX-2 and its metabolite PGE2 are
thought to regulate the function of bone morphogenic protein-2
(BMP-2) and vice versa, which might provide an explanation for
the role of COX-2 during endochondral ossiﬁcation.
In this study, we aim to determine the involvement of COX-
2 in chondrocyte hypertrophy and provide an explanation for
the suppressive effect of NSAIDs on heterotopic ossiﬁcation and
fracture healing.
Methods: To study the role of COX-2 during endochondral ossiﬁ-
cation, ATDC5 cells were differentiated in the chondrogenic lineage
in the presence of BMP-2 for 14 days. The NSAIDs indomethacin
(COX-1/COX-2) or NS398 (COX-2 speciﬁc) were used to inhibit
COX-activity. Expression analysis was performed by RT-qPCR and
western blot (Collagen II, Collagen X, RunX2, COX-2, BMP-2).
Growth curves were obtained from increasing indomethacin- and
NS398-concentrations. Cell numbers were determined by X-violet
staining. Rabbit periosteal grafts were differentiated for 3 weeks
in an agarose sandwich in the presence of BMP-2 (30 ng/nl) and
indomethacin (2 μM) or NS398 (2 μM). Differentiated grafts were
harvested for RT-qPCR and (immuno-)histological analysis. PGE2
production in medium was measured using a speciﬁc ELISA.
Results: Hypertrophic differentiation of ATDC5 cells was obvious
from day 14. Chondrogenesis was accompanied by upregulation of
COX-2 and addition of BMP2 (30 ng/ml) lead to increased upreg-
ulation of COX-2 expression and PGE2 in the media. Accordingly,
expression of Collagen X was also signiﬁcantly upregulated. COX-
2 activity was completely inhibited by indomethacin or NS398.
Surprisingly, speciﬁc inhibition of COX-2 by NS398 did not affect
Collagen II expression whereas expression of RunX2 and Colla-
gen X was signiﬁcantly decreased in a concentration dependent
way. COX-inhibition by indomethacin showed similar results, how-
ever had inhibitory effects on Collagen II expression at higher
concentrations. Expression of BMP-2 decreased upon increasing
NSAID concentrations, conﬁrming a functional connection be-
tween COX-2 and BMP-2. To determine whether COX-inhibition
speciﬁcally affects differentiation, proliferation rate of ATDC5 cells
under proliferating and differentiating conditions was determined.
No signiﬁcant effect on proliferation was detected. Chondrocyte
hypertrophy of periosteal grafts was dependent on BMP-2. This
BMP-2 mediated hypertrophy was suppressed by COX-inhibition
as determined by ELISA, RT-qPCR and histological analysis, con-
ﬁrming our ﬁndings in ATDC5 cells.
Conclusions: Our data show that COX-2 is upregulated during
chondrogenesis and that BMP-2 induces chondrocyte hypertrophy
and COX-2 expression, suggesting a functional connection. Using
two independent systems we were able to show that inhibition of
COX-activity decreased chondrocyte hypertrophy. Insight into the
mechanism by which COX-2 inﬂuences endochondral ossiﬁcation
is essential to understand the effect of NSAIDs on fracture healing.
Our data may provide a novel strategy to improve the outcome of
cartilage regenerative medicine.
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Purpose: Mesenchymal stem cells (MSCs) have been identiﬁed
in human synovial membrane and articular cartilage from patients
with osteoarthritis (OA), but detailed quantiﬁcation studies of MSCs
were not performed. The purpose of this study was to quantitatively
measure the expression of MSC markers in synovial membranes
from human OA (OA) and health joints.
Methods: Synovial membrane-derived cells were isolated from
health and OA joints and characterized by ﬂow cytometry for
hematopoietic (CD34 and CD45) and mesenchymal (CD44, CD29,
CD73, CD90, CD105 and CD271) markers. Chondrogenesis was
assessed by staining for proteoglycans and type II collagen, adi-
pogenesis by using a stain for lipid drops and osteogenesis by
detecting calcium deposits. The co-expression of CD44, CD90,
CD105 and CD271 was determined by immunoﬂuorescence in
OA and normal synovial membranes and spontaneous cartilage
repair.
Results: More than 90% of OA synovial membrane-derived cells
were positive for CD44, CD73, and CD90 and negative for CD34
and CD45. OA synovial membrane-derived cells were also pos-
itive for CD29 (85.23%), CD117 (72.35%) and CD105 (45.5%).
Micropellet analyses showed that culture of the cells with TGF-
beta3 stimulated proteoglycan and type II collagen synthesis.
Synovial membrane-derived cells culture developed lipid droplets
in adipogenic medium and calciﬁcation in oteogenic medium. Cells
positive for MSC markers were diffusely distributed in OA synovial
membranes. In health synovia, these cells were localized in the
subintimal zone. The number of cells expressing MSCs markers
was higher in OA synovial membranes than in synovia from nor-
